CTRI/2023/07/055677招募中Unknown
Rituximab induction in Antineutrophil Cytoplasmic AssociatEd Antibody Associated Vasculitis - A Randomised Control Trial of 2 regimens (RACE) - RACE
Professor Aman Sharma0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Age >18 years,Active vasculitis defined as BVAS = 1.
排除标准
- •1.Any active infection at the time of recruitment.
- •2.Active tuberculosis of any site in last six months.
- •3. Hepatitis B, C or human immunodeficiency virus I/II infection.
- •4.Abnormal liver function tests at the time of recruitment.
- •5.Prior use of Rituximab for remission induction in the last six months.
- •6.Active malignancy or history of malignancy in the last 5 years.
研究者
相似试验
已完成
2 期
Acquired Immunodeficiency in ANCA Associated VasculitisSystemic VasculitisNCT03514979Cambridge University Hospitals NHS Foundation Trust114
招募中
不适用
Desensitization with rituximab for preformed anti-donor antibody and antibody-mediated rejection in kidney transplantation.end stage renal diseaseJPRN-UMIN000032113Hyogo College of Medicine90
招募中
不适用
The study of ANCA for efficacy of biologics therapy in patients with ulcerative colitislcerative colitisJPRN-UMIN000043883Center for Gastroenterology and Inflammatory Bowel Disease, Ofuna Chuo Hospital200
已完成
2 期
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic PolyangiitisWegener's GranulomatosisVasculitisMicroscopic PolyangiitisNCT00104299National Institute of Allergy and Infectious Diseases (NIAID)197
已完成
3 期
Clinical study of Rituximab for inhibition of antibody mediated rejection in ABO-incompatible kidney transplantatioChronic kidney disease patient to whom ABO incompatibility kidney transplantation is planned.JPRN-UMIN000006635Zenyaku Kogyo Co., Ltd.23